Germ-Line<i>BRCA1</i>Mutations in Jewish and Non-Jewish Women with Early-Onset Breast CancerMichael G. FitzGerald, Daniel A. Haber, Erin O'Neil et al.|New England Journal of Medicine|1996Cited by 388
Heterozygous ATM mutations do not contribute to early onset of breast cancerMichael G. FitzGerald, Daniel A. Haber, James Bean et al.|Nature Genetics|1997Cited by 343
A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus InfectionSamuel A. Bozzette, Judith Feinberg, Dianne M. Finkelstein et al.|New England Journal of Medicine|1995Cited by 339
Differential Contributions of<i>BRCA1</i>and<i>BRCA2</i>to Early-Onset Breast CancerMichael Krainer, Daniel A. Haber, Sandra Silva-Arrieta et al.|New England Journal of Medicine|1997Cited by 211
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.Michael G. FitzGerald, Daniel A. Haber, D. Paul Harkin et al.|Proceedings of the National Academy of Sciences|1996Cited by 201